Priority Date: 14.03.12 (US 201261610682P)

THERAPEUTIC USE OF P75NTR NEUROTROPHIN BINDING PROTEIN

  • Application ID: EP13711109
  • Status: PATENT GRANTED

Attorneys

no operation time available
3 offices
active in Legal Services
operating since 1887
1447.4
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading
operating since 1887
1447.4
Headquarter in London and 20 offices
active in Legal Services, IP Consulting, and Matchmaking and Trading
no operation time available
Headquarter in Kent
active in Legal Services

Specialization

This EP application has the IPC combination A61, C07, and C12. Rouse IP Limited is specialized in the combination A61, C07, and C12. We found, that TransMIT GmbH, Kailuweit & Uhlemann, Lederer Keller Patentanwälte Partnerschaft mbB, Vossius & Partner Patentanwälte Rechtsanwälte mbB, df-mp Dörries Frank-Molnia & Pohlman, Patentanwälte Rechtsanwälte PartG mbB and 121 others are specialized in all of these IPC classes as well. For a similar patent, they might be a good choice.

Timeline

  • 14.03.2012 - Priority Date (US 201261610682P)
  • 19.09.2013 - Publication A1 (WO2013136078)
  • 21.01.2015 - Publication A1 (EP2825208)
  • 17.05.2017 - Publication B1 (EP2825208)